XFOR - X4 Pharmaceuticals Inc
4.15
0.390 9.398%
Share volume: 590,387
Last Updated: 03-09-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$3.76
0.39
0.10%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-07-2024 | 08-08-2024 | 11-13-2024 | 03-25-2025 | 05-01-2025 | 08-08-2025 | 11-05-2025 | |
| Cash flow financing | 0.000 | 20.159 M | 0.000 | 135.000 K | 0.000 | 5.631 M | 86.905 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -38.919 M | 86.744 M | 0.000 | -41.481 M | -15.506 M | -1.158 M | 30.414 M | |
| Net income | -51.766 M | 90.833 M | -36.696 M | -39.821 M | 282.000 K | -25.741 M | -29.815 M | |
| Depreciation | 62.000 K | 194.000 K | 267.000 K | 273.000 K | 476.000 K | 355.000 K | 223.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 272.000 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -5.322 M | 96.862 M | -15.929 M | -8.621 M | -3.138 M | 23.112 M | -28.669 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 59.000 K | 134.000 K | 92.000 K | 41.000 K | 0.000 | 0.000 | 0.000 | |
| Cash Change | -38.978 M | 86.726 M | -49.796 M | -41.725 M | -15.434 M | -1.019 M | 30.413 M |